Naloxone

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Texas

Top of the article
07.25.16

WOONSOCKET, R.I., July 25, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Texas. CVS Health has established a standing order with physicians in Texas that allows CVS Pharmacy to expand access to the medication across the state.

CVS Pharmacist counsels patient about the opioid overdose-reversal drug naloxone

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Texas pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."

In addition to Texas, CVS Pharmacy locations in 30 other states will be able to dispense naloxone to patients without an individual prescription by August 2016.

"CVS Health has been a leader in helping communities prevent prescription drug abuse and we applaud their work to increase access to this life-saving drug for patients without a prescription at CVS Pharmacy locations in Texas," said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. "Increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction."

CVS Health has also launched digital resources on www.cvs.com/content/prescription-drug-abuse giving patients and families a single destination to learn more about drug abuse prevention. These new resources build on CVS Health's longstanding commitment to helping communities address and prevent drug abuse. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 100,000 students have already taken part in the program. High school teachers and administrators in Texas can learn more about bringing Pharmacists Teach to their school here.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. The program has already donated 37 units to police departments in the state and collected more than two and a half metric tons of unwanted medications in Texas. Law enforcement officials across Texas can apply to receive a drug collection unit here.

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

CVS Health

Photo - http://photos.prnewswire.com/prnh/20160722/392215
Logo - http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Oklahoma

Top of the article
11.09.17

Naloxone now available at CVS Pharmacy locations in 42 states

WOONSOCKET, R.I., Nov. 9, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the 77 CVS Pharmacy locations in Oklahoma, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide protocol giving pharmacists prescriptive authority to dispense naloxone.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Oklahoma we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. "CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."

"In Oklahoma, more adults die of unintentional prescription drug overdoses than in car crashes," said Congressman Markwayne Mullin. "Now, thanks to the passage of 21st Century Cures Act and the Comprehensive Addiction and Recovery Act, law enforcement, physicians, and prescribers have more tools than ever to fight the opioid crisis. By making this lifesaving drug readily accessible to all Oklahomans, we can reverse the effects of drug overdose and prevent drug overdose tragedies in the future. Our fight against the opioid crisis does not end here, but it's great to see a commonsense solution that will save the lives of thousands of Oklahomans each year. Just like seatbelts have helped significantly reduce car accident deaths, so will naloxone help reduce the lives tragically lost each year to drug overdose."

Today's naloxone announcement builds on CVS Health's commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Oklahoma, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Oklahoma, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
Yes
Press Release
"Likes" Count
0

CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Michigan

Top of the article
11.09.17

Naloxone now available at CVS Pharmacy locations in 43 states

WOONSOCKET, R.I., Nov. 9, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without an individual prescription at all of the nearly 300 CVS Pharmacy locations in Michigan, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide standing order protocol.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Michigan we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. "CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."

"Michigan families have lost too many loved ones to the opioid epidemic," said U.S. Senator Debbie Stabenow. "Naloxone is a critical life-saving drug for those who suffer from addiction and I applaud those working to make it more accessible."

Today's naloxone announcement builds on CVS Health's commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Michigan, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Michigan, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
Yes
Press Release
"Likes" Count
0

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Nevada

Top of the article
12.14.16

WOONSOCKET, R.I., Dec. 14, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. CVS Health has established a standing order with physicians in Nevada that allows CVS Pharmacy to expand access to the medication across the state.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Nevada pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."

The move to expand access to naloxone builds on CVS Health's longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health's commitment to drug abuse prevention education extends from online resources for patients visiting CVS.com to a commitment to youth prevention programs. Launched in 2015, CVS Health's Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to local students about the dangers of drug abuse. More than 150,000 students have already been part of the program. The CVS Health Foundation is also working with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country. The program gives members of the community a safe and environmentally friendly way to dispose of unwanted medication and has already collected more than 47 metric tons of prescription drugs.

"CVS Health has been a leader in the work of helping communities prevent prescription drug abuse," said Marcia Lee Taylor, President and CEO, Partnership for Drug-Free Kids. "In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction."

With the addition of Nevada, CVS Pharmacy now dispenses naloxone in a total of 37 states: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Florida, Idaho, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

Logo - http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Delaware

Top of the article
11.09.17

Naloxone now available at CVS Pharmacy locations in 46 states

WOONSOCKET, R.I., Nov. 9, 2017 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without an individual prescription at the 20 CVS Pharmacy locations in Delaware, including those located inside Target stores. CVS Pharmacists will be able to dispense naloxone to patients without an individual prescription under a statewide standing order protocol.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Delaware we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Services at CVS Pharmacy. "CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."

"Our first priority is to save lives, and expanding access to this overdose-reversing medication through local pharmacies gives more people in the community the opportunity to help us do that," said Dr. Karyl Rattay, Director of Delaware Health and Social Services Division of Public Health. "We see no signs of the opioid epidemic slowing and we need all the tools at our disposal to turn the tide."

Today's naloxone announcement builds on CVS Health's commitment to helping communities address and prevent prescription drug abuse by focusing on prevention and safe medication disposal. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings CVS pharmacists to local schools to talk to students about the dangers of drug abuse. More than 300,000 students across the U.S. have already taken part in the program. High school teachers and administrators can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 800 units to police departments around the country, collecting more than 100 metric tons of unwanted medication. In September, CVS Health announced it would expand the program to 750 locations inside CVS Pharmacies by mid-2018, for a total of 1,550 safe medication disposal locations.

In that recent announcement, the company also said it would enhance opioid utilization management to align with the CDC Guideline for CVS Caremark PBM clients and members, complementing measures already in place. And, the CVS Health Foundation added a $2 million commitment to previous investments in mitigating prescription drug abuse with support for Community Health Centers providing medication-assisted treatment and other addiction recovery services.

With the addition of Delaware, CVS Pharmacy now dispenses naloxone to patients without an individual prescription in these 46 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Delaware, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

Boston Medical Center Teams Up with Rhode Island Hospital, CVS Health to Address Use of Pharmacy-Based Naloxone to Combat Opioid Addiction and Overdoses

Top of the article
08.10.15

BOSTONBoston Medical Center (BMC) has received a $1.3 million grant from the Agency for Healthcare Research and Quality (AHRQ) to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose death in two New England States: Massachusetts and Rhode Island. The study will be conducted in partnership with Rhode Island Hospital in Providence, CVS Health, based in Woonsocket, Rhode Island, which has pharmacies throughout the U.S., and several local community pharmacies in both states, including Massachusetts-based Eaton Apothecary.

“While education and intervention have come a long way in the past several years, there is still a lot of work to be done to reduce opioid overdose and overdose death,” said the study’s principal investigator, Traci C. Green, PhD, MSc, deputy director of the Injury Prevention Center at BMC and associate professor of emergency medicine at The Warren Alpert Medical School of Brown University. “Pharmacies have enormous potential to expand the reach and impact of critical public health interventions, just as we have seen happen with pharmacy access to clean syringes and adult immunizations. But how do we do that with naloxone rescue kits? That’s what we intend to figure out here in Massachusetts and Rhode Island.”

In both states, pharmacists must be trained to distribute naloxone rescue kits through continuing education that covers opioid addiction, overdose risk and the benefits of appropriate use of naloxone. The study will track and analyze data from the participating pharmacies throughout the two states to develop best practices for a national pharmacy-based naloxone rescue kit program.

To address the growing opioid epidemic, hospitals and pharmacies in both states recently began providing naloxone to patients with substance use disorder and their loved ones for immediate use following an overdose. Uniquely, under a standing order from BMC’s Alexander Walley, MD, the medical director of the Massachusetts naloxone program and also a Co-Investigator on this study, state-funded community programs train and equip family, friends, and people who use opioids in overdose recognition and naloxone administration. Similar infrastructure is absent in most states, such as Rhode Island. The study will look at how pharmacies can be leveraged in both settings to increase naloxone distribution.

As a leader in addiction medicine, BMC recognized early on the need for such interventions, and in 2009, began providing overdose prevention education and naloxone rescue kits to emergency department patients at risk for opioid overdose. BMC was the first hospital in the country to provide the rescue kits to patients.

Green and Walley, in collaboration with Josiah Rich, MD, MPH, a physician at The Miriam Hospital in Providence, and Jeffrey Bratberg, PharmD, from the University of Rhode Island College of Pharmacy, developed protocols for pharmacies to supply, order and provide naloxone to patients. The protocols are in place throughout Massachusetts and Rhode Island pharmacies, including the 418 CVS pharmacies and all Eaton Apothecary locations in the two states. The authors will identify relevant organizational and community factors associated with successful implementation of the program to incorporate into a national program.

“In Massachusetts and Rhode Island, we have been severely impacted by the epidemic of overdose deaths,” said Rich, who also is professor of medicine and epidemiology at the Alpert Medical School of Brown University. “Rhode Island Hospital is honored to partner with BMC, CVS and other local pharmacies to develop a new standard of care that we expect will prevent deaths caused by opioid overdoses.”

Drug overdose is the leading cause of injury death in the U.S., greater than car accidents. In fact, according to the Substance Abuse Mental Health Services Administration, more than 24.5 million people age 12 or older in the U.S. (9.4 percent of the population) live with substance use disorders, including 1.9 million who live with prescription opioid abuse or dependence. Each day, according to Centers for Disease Control and Prevention, 100 Americans die of drug overdose.

”CVS Health has a long-standing commitment to prevent prescription drug abuse and our participation in this demonstration project complements our ongoing efforts to expand the availability and distribution of naloxone to prevent opioid overdoses,” said William Shrank, MD, chief scientific officer of CVS Health and a study investigator. “All of our CVS/pharmacy locations in Rhode Island and Massachusetts keep naloxone in stock and it is available without a prescription. In addition, by the end of this month, CVS/pharmacy will be able to dispense naloxone without a prescription in 14 additional states.”

Naloxone can be obtained from pharmacies without a prescription in Massachusetts and Rhode Island.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 496-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $118 million in sponsored research funding in fiscal year 2014. It is the 11th largest recipient of funding in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. It does business in Massachusetts as BMC HealthNet Plan and as Well Sense Health Plan in New Hampshire, serving more than 315,000 people, collectively. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet – 13 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.

About Rhode Island Hospital

Founded in 1863, Rhode Island Hospital in Providence, R.I., is a private, not-for-profit hospital and is the principal teaching hospital of the Alpert Medical School of Brown University. A major trauma center for southeastern New England, the hospital is dedicated to being on the cutting edge of medicine and research. Last year, Rhode Island Hospital received more than $50 million in external research funding. It is also home to Hasbro Children’s Hospital, the state’s only facility dedicated to pediatric care. For more information, visit www.rhodeislandhospital.org.

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

About the University of Rhode Island and its College of Pharmacy

The University of Rhode Island has many of today’s leading innovators, researchers and creative problem solvers. The University is known regionally and worldwide for its big ideas and pioneering research in such areas as air, water, and ground pollution; biotechnology and life sciences; engineering, marine sciences, forensic sciences, pharmaceuticals, behavioral sciences, and public health promotion. Unique interdisciplinary courses and research projects provide its 13,000 undergraduate and 3,000 graduate students with cutting-edge experiences. URI’s College of Pharmacy is located in a new, $75 million facility where faculty and students are conducting the highest quality research in pharmaceutical, biomedical, clinical and population-based sciences. The College is also going deep into the ocean and forest to find natural substances that could prevent and fight diseases. Target areas include cancer, aging, diabetes, Alzheimer’s disease, HIV, infectious diseases, disability and public health. The College has attracted about $61 million in National Institutes of Health funding to expand biomedical research capacity at nearly every college in the state and is playing leading roles in URI’s Interdisciplinary Neuroscience Program and the George & Anne Ryan Institute for Neuroscience.

Media Contacts

Boston Medical Center – Jenny Eriksen Leary, jenny.eriksen@bmc.org, 617-638-6841

Rhode Island Hospital – Beth Bailey, bbailey@lifespan.org, 401-444-6421

CVS Health – Christine Cramer, Christine.Cramer@CVSHealth.com, 401-770-3317

URI College of Pharmacy – Dave Lavallee, dlavallee@uri.edu, 401-874-5862

Press Release
"Likes" Count
0

CVS/pharmacy commits to Creating Safer Communities Through Multiple Prescription Drug Abuse Prevention Efforts

Top of the article
09.23.15

WOONSOCKET, R.I., Sept. 23, 2015 /PRNewswire/ -- CVS/pharmacy, the retail division of CVS Health (NYSE: CVS), is reinforcing its longstanding commitment in the fight against the nationwide epidemic of prescription drug abuse with a number of efforts launching this month.

CVS/pharmacy has expanded the availability of the opioid overdose reversal medicine, naloxone, in several states. The medication was already available at CVS/pharmacy without a prescription in Rhode Island and Massachusetts. Naloxone is now available without a prescription at CVS/pharmacy locations in 12 additional states: Arkansas, California, Minnesota, Mississippi, Montana, New Jersey, North Dakota, Pennsylvania, South Carolina, Tennessee, Utah and Wisconsin.

"Over 44,000 people die from accidental drug overdoses every year in the United States and most of those deaths are from opioids, including controlled substance pain medication and illegal drugs such as heroin. Naloxone is a safe and effective antidote to opioid overdoses and by providing access to this medication in our pharmacies without a prescription in more states, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS/pharmacy. "While all 7,800 CVS/pharmacy stores nationwide can continue to order and dispense naloxone when a prescription is presented, we support expanding naloxone availability without a prescription and are reviewing opportunities to do so in other states."

In addition, CVS Health is currently participating in a research project with Boston Medical Center and Rhode Island Hospital to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose deaths.

CVS/pharmacy has also renewed its Medication Disposal for Safer Communities Program, in which it has teamed up with the Partnership for Drug-Free Kids to donate drug collection units to police departments around the country to help their communities safely dispose of unwanted medications, including controlled substances.

"Our Safer Communities program has donated more than 400 drug collection units to local law enforcement around the country since last year, resulting in almost seven tons of unused medication being collected in our communities," said Davis. "We are pleased to continue this program with the Partnership for Drug-Free Kids and provide a permanent drug disposal solution at local police departments."

Police departments interested in receiving a drug collection unit can apply at www.cvs.com/safercommunities.

Also, the Drug Enforcement Administration (DEA) will hold National Prescription Drug Take-Back Day on Saturday, September 26. On that day, hundreds of CVS/pharmacy locations around the country will host local law enforcement collection events in store parking lots from 10:00 AM to 2:00 PM. To locate a participating collection site, visit http://www.deadiversion.usdoj.gov/drug_disposal/takeback/.

Other on-going initiatives at CVS/pharmacy to combat prescription drug abuse include:

  • Availability of postage-paid Environmental Return System envelopes at all of its pharmacies with which customers can send their unwanted medications for secure and environmentally-safe disposal.
  • Identification of physicians who exhibit extreme patterns of prescribing high risk drugs such as pain medications and suspension of dispensing their controlled substance prescriptions.
  • Advocating at the federal and state levels to implement policy changes to curb prescription drug abuse, such as mandatory electronic prescribing of controlled substances and improved prescription drug monitoring programs.

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Health (NYSE: CVS), is America's leading retail pharmacy with over 7,800 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Health is available at www.cvshealth.com.

MEDIA CONTACT:

Mike DeAngelis
mjdeangelis@cvs.com
401-770-2645

Logo - http://photos.prnewswire.com/prnh/20100816/NE50800LOGO

SOURCE CVS/pharmacy

Press Release
"Likes" Count
0

CVS Health To Make Overdose-Reversing Drug Available Without A Prescription At All CVS Pharmacy Locations Across Ohio

Top of the article
02.01.16

TOLEDO, Ohio, Feb. 1, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today it would make the opioid overdose reversal medicine naloxone available without a prescription at all CVS Pharmacy locations across Ohio beginning in late March 2016. White House National Drug Control Policy Director Michael Botticelli, Ohio Attorney General Mike DeWine and Lucas County Sheriff John Tharp joined CVS Health in making the announcement at a press conference in Toledo today.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Ohio pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We support expanding naloxone availability and we applaud the State of Ohio for its leadership in the fight against drug abuse and addiction."

"Today's announcement builds on the commitment CVS Health made last October when President Obama announced new public and private sector actions to address prescription drug abuse and heroin use," said White House Director of National Drug Control Policy Michael Botticelli. "Expanding access to the lifesaving overdose-reversal drug naloxone is a critical part of our national strategy to stop the opioid overdose epidemic, along with effective enforcement, prevention, and treatment."

"By making naloxone available at their stores without an individual prescription, CVS Pharmacies will be helping to put a life-saving tool in the hands of Ohioans who may have a family member or someone close to them suffering from an opiate addiction," said Ohio Attorney General Mike DeWine. "Many of our first responders carry naloxone, but having it available on a wider basis could get help to someone who is overdosing even more quickly."

"It shouldn't be easier for Ohioans to get opioids than it is to get life-saving medication necessary to stop overdoses," said U.S. Senator Sherrod Brown, who has partnered with CVS Health on several efforts to curb prescription drug abuse, including the Stopping Medication Abuse and Protecting Seniors Act, which would allow pharmacies to use drug-management programs in Medicare. "As trusted institutions in the community, pharmacies have an important role to play in our collective fight against addiction to opioids and heroin. CVS Health's commitment to solving this problem by making overdose-reversing medications available to patients, first responders, and caregivers without an individual prescription shows it takes this responsibility seriously. We need to use every resource available to prevent and treat addiction and drug overdoses and help save lives in Toledo and across Ohio, and I will continue to work with my colleagues, the Administration, and community members to fight this public health crisis."

"By increasing access to the life-saving drug naloxone, we can help bring more people back from the grips of overdoses," U.S. Senator Rob Portman stated. "This marks an important step in our fight to combat addiction and I will continue to work for a bottom-up, comprehensive approach to the heroin epidemic."

CVS Health is also providing the opportunity for law enforcement agencies in Ohio to apply to receive a drug collection unit to help local communities safely dispose of unwanted medications, including controlled substances. Through the Medication Disposal for Safer Communities Program, a joint effort of CVS Pharmacy and The Partnership for Drug-Free Kids, more than 20 drug disposal units donated across Ohio have collected more than 4,000 pounds of unwanted medications since September 2014. And nation-wide, the program has donated more than 500 drug collection units and collected more than 28 metric tons of unwanted medications.

In the Toledo area, the Safer Communities program has donated drug collection units to the Ottawa Hills Police Department, the City of Oregon Police Department and the Lucas County Coroner's Office. Law enforcement officials can learn more about the program and apply for a unit here or by calling 866-559-8830.

Lucas County Sheriff John Tharp said "Saving the lives of our family, friends, and neighbors is imperative and any tools to help combat the current heroin epidemic in our communities should be embraced."

CVS Health is also highlighting its community outreach program called "Pharmacists Teach," which gives high school students the opportunity to hear from local CVS pharmacists about the dangers of prescription drug abuse. School administrators in Ohio can learn more about this opportunity and request to participate in the program by emailing PharmacistsTeach@cvshealth.com. Nation-wide, more than 5,000 students have already participated in the program.

CVS Health's move to increase access to naloxone in Ohio comes in addition to more than a dozen states where naloxone is already available without a prescription at CVS Pharmacy locations including Arkansas, California, Indiana, Minnesota, Mississippi, Montana, New Jersey, New York, North Dakota, Pennsylvania, Tennessee, Utah and Wisconsin.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

Logo - http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in New Hampshire

Top of the article
04.28.16

WOONSOCKET, R.I., April 28, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) announced today it has made the opioid overdose reversal medication naloxone available without a prescription at all CVS Pharmacy locations in New Hampshire. CVS Health has established a standing order with physicians in New Hampshire that allows CVS Pharmacy to expand access to the medication in the Granite State.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our New Hampshire pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We support expanding naloxone availability to give more people a chance to get the help they need for recovery and we applaud the State of New Hampshire for its leadership in the fight against drug abuse and addiction."

"The opioid epidemic has touched so many families in New Hampshire and across the U.S. and expanding access to naloxone is one important step in our efforts to address it," said Marcia Lee Taylor, President and CEO of the Partnership for Drug-Free Kids. "We applaud CVS Health for increasing access to this life-saving drug for patients without a prescription at CVS Pharmacy locations in New Hampshire and in many other states across the country."

CVS Health has also launched digital resources on www.cvs.com/content/prescription-drug-abuse giving patients and families a single destination to learn more about drug abuse prevention. These new resources build on CVS Health's longstanding commitment to helping communities address and prevent drug abuse. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 60,000 students have already taken part in the program. High school teachers and administrators in New Hampshire can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. The program has already donated twelve units to police departments in the state and collected more than 1,665 pounds of unwanted medications in New Hampshire. Law enforcement officials across New Hampshire can apply to receive a drug collection unit at www.cvs.com/safercommunities.

In addition to New Hampshire, CVS Pharmacy locations in 22 other states can now dispense naloxone to patients without an individual prescription.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its approximately 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 75 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

Logo -http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0

CVS Health, Governor McAuliffe Highlight Availability of Overdose-Reversing Medication At All CVS Pharmacy Locations Across Virginia

Top of the article
05.11.16

RICHMOND, Va., May 11, 2016 /PRNewswire/ -- CVS Health (NYSE: CVS) today joined Virginia Governor Terry McAuliffe, Health and Human Resources Secretary William Hazel and Secretary of Public Safety and Homeland Security Brian Moran in highlighting the availability of the opioid overdose-reversal medicine naloxone without a prescription at all CVS Pharmacy locations across Virginia. CVS Health has established a standing order with physicians in Virginia that allows CVS Pharmacy to expand access to the medication in the Old Dominion.

"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Virginia pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS Pharmacy. "We support expanding naloxone availability to give more people a chance to get the help they need for recovery and we applaud Governor McAuliffe and the State of Virginia for their leadership in the fight against drug abuse and addiction."

"Drug overdose is the Number One cause of unnatural death in Virginia, and it has been for the past three years," said Governor McAuliffe. "It takes the lives of more Virginians than motor vehicle accidents or firearms. Preliminary numbers indicate that about 1,000 Virginians died of drug overdose last year, including more than 500 from prescription opioids and 300 from heroin. So we know that this particular class of narcotic, which includes both prescription and illegal drugs, is the primary killer that we must confront if we are going to end this epidemic. CVS Health's decision to make naloxone available without a prescription at all of its Virginia locations is a welcome and important step that will save lives here in Virginia."

"Prescription opioid and heroin overdoses are killing our citizens, and we need to use every tool we can to fight that epidemic," said Secretary Hazel. "We are working to reduce the amount of available opioids, whether they are the kind that gets prescribed or the kind that gets bought on the street corner. We are looking to increase treatment options and trying to find ways to divert people who are addicted away from jails and into treatment. But having a drug like naloxone that can reverse a potentially fatal overdose is, quite literally, a life-saver. The more available it is, the more lives can be saved."

"We allow and encourage our first responders to carry this life-saving drug, and to know how to use it," said Secretary Moran. "But families and friends of people with addiction are often the actual first people to encounter a person who has overdosed. Making naloxone more easily available to them at drugstores like CVS is one step toward saving a life."

CVS Health has also launched new digital resources on www.cvs.com/content/prescription-drug-abuse giving patients and families a single destination to learn more about drug abuse prevention. These new resources build on CVS Health's longstanding commitment to helping communities address and prevent drug abuse. In 2015, CVS Health launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. More than 75,000 students have already taken part in the program. High school teachers and administrators in Virginia can learn more about bringing Pharmacists Teach to their school at www.CVSHealth.com.

CVS Health has also joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments, providing a safe and environmentally friendly way to dispose of unwanted medication. In Virginia, 45 police departments have received units through the program, which have collected nearly two and a half metric tons of unwanted medication in the state. And across the country, this program has collected more than 35 metric tons of unwanted medication. Police departments in Virginia can apply to receive a drug collection unit at www.cvs.com/safercommunities.

In addition to Virginia, CVS Pharmacy locations in 22 states can dispense naloxone to patients without an individual prescription.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Media Contact:

Erin Shields Britt
Corporate Communications
(401) 770-9237
Erin.Britt@CVSHealth.com

Brian Coy
Director of Communications
Office of the Governor
Brian.Coy@governor.virginia.gov

Logo - http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

Hide Media Contacts (Sidebar)
No
Press Release
"Likes" Count
0